Immunological analysis of mucin molecules expressed by normal and malignant mammary epithelial cells

A. B. Griffiths, J. Burchell, Sandra J Gendler, A. Lewis, K. Blight, R. Tilly, J. Taylor-Papadimitriou

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Many existing MAbs raised against the human milk fat globule or against carcinoma cells recognise epitopes on high-molecular-weight glycoproteins. In a comparative ELISA assay a number of these antibodies have been shown to react with an extract of the human milk fat globule. In comparative immunoblots of cultured normal milk cells and breast cell lines, all were found to bind to large molecules which show some variation in molecular weight depending on the cell source. The HMFG-2 antibody, which is widely used in cancer diagnosis, also recognises epitopes on lower-molecular-weight components. In T47D cells these may be as small as 80,000 M(r), and with electron microscopy this cell line can be shown to accumulate HMFG-2-reactive components in the Golgi apparatus. Using an HMFG-2 affinity column we have immunopurified HMFG-2-reactive material from the 2 breast cancer cell lines MCF-7 and T47D and shown that all of the above antibodies react in a solid-phase ELISA with the purified material. In addition to high-molecular-weight components, the immunopurified material was found to contain lower-molecular-weight components including a glycoprotein of 68,000 M(r) that was not, however, recognised by the HMFG-2 antibody on a Western blot. We have used this immunopurified material to generate new MAbs. All of these recognise the high-molecular-weight bands seen with the other antibodies, but 2 of them also recognise a band at 68,000 M(r) in blots of MCF-7 and T47D. The second-generation antibodies show a spectrum of reactivity on tissues similar to HMFG-2 and one reacts at least as strongly as HMFG-2 with methanol-acetone-fixed sections of breast cancers.

Original languageEnglish (US)
Pages (from-to)319-327
Number of pages9
JournalInternational Journal of Cancer
Volume40
Issue number3
StatePublished - 1987
Externally publishedYes

Fingerprint

Mucins
Breast
Molecular Weight
Epithelial Cells
Antibodies
Human Milk
Cell Line
Epitopes
Glycoproteins
Enzyme-Linked Immunosorbent Assay
Breast Neoplasms
Golgi Apparatus
Acetone
Methanol
Electron Microscopy
Western Blotting
Carcinoma
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Griffiths, A. B., Burchell, J., Gendler, S. J., Lewis, A., Blight, K., Tilly, R., & Taylor-Papadimitriou, J. (1987). Immunological analysis of mucin molecules expressed by normal and malignant mammary epithelial cells. International Journal of Cancer, 40(3), 319-327.

Immunological analysis of mucin molecules expressed by normal and malignant mammary epithelial cells. / Griffiths, A. B.; Burchell, J.; Gendler, Sandra J; Lewis, A.; Blight, K.; Tilly, R.; Taylor-Papadimitriou, J.

In: International Journal of Cancer, Vol. 40, No. 3, 1987, p. 319-327.

Research output: Contribution to journalArticle

Griffiths, AB, Burchell, J, Gendler, SJ, Lewis, A, Blight, K, Tilly, R & Taylor-Papadimitriou, J 1987, 'Immunological analysis of mucin molecules expressed by normal and malignant mammary epithelial cells', International Journal of Cancer, vol. 40, no. 3, pp. 319-327.
Griffiths, A. B. ; Burchell, J. ; Gendler, Sandra J ; Lewis, A. ; Blight, K. ; Tilly, R. ; Taylor-Papadimitriou, J. / Immunological analysis of mucin molecules expressed by normal and malignant mammary epithelial cells. In: International Journal of Cancer. 1987 ; Vol. 40, No. 3. pp. 319-327.
@article{c27f903514e146188894152f012362d4,
title = "Immunological analysis of mucin molecules expressed by normal and malignant mammary epithelial cells",
abstract = "Many existing MAbs raised against the human milk fat globule or against carcinoma cells recognise epitopes on high-molecular-weight glycoproteins. In a comparative ELISA assay a number of these antibodies have been shown to react with an extract of the human milk fat globule. In comparative immunoblots of cultured normal milk cells and breast cell lines, all were found to bind to large molecules which show some variation in molecular weight depending on the cell source. The HMFG-2 antibody, which is widely used in cancer diagnosis, also recognises epitopes on lower-molecular-weight components. In T47D cells these may be as small as 80,000 M(r), and with electron microscopy this cell line can be shown to accumulate HMFG-2-reactive components in the Golgi apparatus. Using an HMFG-2 affinity column we have immunopurified HMFG-2-reactive material from the 2 breast cancer cell lines MCF-7 and T47D and shown that all of the above antibodies react in a solid-phase ELISA with the purified material. In addition to high-molecular-weight components, the immunopurified material was found to contain lower-molecular-weight components including a glycoprotein of 68,000 M(r) that was not, however, recognised by the HMFG-2 antibody on a Western blot. We have used this immunopurified material to generate new MAbs. All of these recognise the high-molecular-weight bands seen with the other antibodies, but 2 of them also recognise a band at 68,000 M(r) in blots of MCF-7 and T47D. The second-generation antibodies show a spectrum of reactivity on tissues similar to HMFG-2 and one reacts at least as strongly as HMFG-2 with methanol-acetone-fixed sections of breast cancers.",
author = "Griffiths, {A. B.} and J. Burchell and Gendler, {Sandra J} and A. Lewis and K. Blight and R. Tilly and J. Taylor-Papadimitriou",
year = "1987",
language = "English (US)",
volume = "40",
pages = "319--327",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Immunological analysis of mucin molecules expressed by normal and malignant mammary epithelial cells

AU - Griffiths, A. B.

AU - Burchell, J.

AU - Gendler, Sandra J

AU - Lewis, A.

AU - Blight, K.

AU - Tilly, R.

AU - Taylor-Papadimitriou, J.

PY - 1987

Y1 - 1987

N2 - Many existing MAbs raised against the human milk fat globule or against carcinoma cells recognise epitopes on high-molecular-weight glycoproteins. In a comparative ELISA assay a number of these antibodies have been shown to react with an extract of the human milk fat globule. In comparative immunoblots of cultured normal milk cells and breast cell lines, all were found to bind to large molecules which show some variation in molecular weight depending on the cell source. The HMFG-2 antibody, which is widely used in cancer diagnosis, also recognises epitopes on lower-molecular-weight components. In T47D cells these may be as small as 80,000 M(r), and with electron microscopy this cell line can be shown to accumulate HMFG-2-reactive components in the Golgi apparatus. Using an HMFG-2 affinity column we have immunopurified HMFG-2-reactive material from the 2 breast cancer cell lines MCF-7 and T47D and shown that all of the above antibodies react in a solid-phase ELISA with the purified material. In addition to high-molecular-weight components, the immunopurified material was found to contain lower-molecular-weight components including a glycoprotein of 68,000 M(r) that was not, however, recognised by the HMFG-2 antibody on a Western blot. We have used this immunopurified material to generate new MAbs. All of these recognise the high-molecular-weight bands seen with the other antibodies, but 2 of them also recognise a band at 68,000 M(r) in blots of MCF-7 and T47D. The second-generation antibodies show a spectrum of reactivity on tissues similar to HMFG-2 and one reacts at least as strongly as HMFG-2 with methanol-acetone-fixed sections of breast cancers.

AB - Many existing MAbs raised against the human milk fat globule or against carcinoma cells recognise epitopes on high-molecular-weight glycoproteins. In a comparative ELISA assay a number of these antibodies have been shown to react with an extract of the human milk fat globule. In comparative immunoblots of cultured normal milk cells and breast cell lines, all were found to bind to large molecules which show some variation in molecular weight depending on the cell source. The HMFG-2 antibody, which is widely used in cancer diagnosis, also recognises epitopes on lower-molecular-weight components. In T47D cells these may be as small as 80,000 M(r), and with electron microscopy this cell line can be shown to accumulate HMFG-2-reactive components in the Golgi apparatus. Using an HMFG-2 affinity column we have immunopurified HMFG-2-reactive material from the 2 breast cancer cell lines MCF-7 and T47D and shown that all of the above antibodies react in a solid-phase ELISA with the purified material. In addition to high-molecular-weight components, the immunopurified material was found to contain lower-molecular-weight components including a glycoprotein of 68,000 M(r) that was not, however, recognised by the HMFG-2 antibody on a Western blot. We have used this immunopurified material to generate new MAbs. All of these recognise the high-molecular-weight bands seen with the other antibodies, but 2 of them also recognise a band at 68,000 M(r) in blots of MCF-7 and T47D. The second-generation antibodies show a spectrum of reactivity on tissues similar to HMFG-2 and one reacts at least as strongly as HMFG-2 with methanol-acetone-fixed sections of breast cancers.

UR - http://www.scopus.com/inward/record.url?scp=0023618234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023618234&partnerID=8YFLogxK

M3 - Article

VL - 40

SP - 319

EP - 327

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 3

ER -